Hyperphagic Effects of Brainstem Ghrelin Administration

  1. Lucy F. Faulconbridge1,
  2. David E. Cummings2,
  3. Joel M. Kaplan1 and
  4. Harvey J. Grill1
  1. 1Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania
  2. 2Department of Medicine, University of Washington, VA Puget Sound Health Care System, Seattle, Washington
  1. Address correspondence and reprint requests to Lucy F. Faulconbridge, Department of Psychology, University of Pennsylvania, 3815 Walnut St., Philadelphia, PA 19104. E-mail: lucyhf{at}psych.upenn.edu

Abstract

The role of ghrelin in feeding control has been addressed from a largely hypothalamic perspective, with little attention directed at ingestive consequences of stimulation of the peptide’s receptor, the growth hormone secretagogue receptor (GHS-R), in the caudal brainstem. Here, we demonstrate a hyperphagic response to stimulation of GHS-R in the caudal brainstem. Ghrelin (150 pmol) delivered to the third and fourth ventricles significantly and comparably increased cumulative food intake, with maximal response ∼3 h after injection. The meal patterning effects underlying this hyperphagia were also similar for the two placements (i.e., significant reduction in the time between injection and first-meal onset, an increase in the number of meals taken shortly after the injection, and a trend toward an increase in the average size of the first meals that approached but did not achieve statistical significance). In a separate experiment, ghrelin microinjected unilaterally into the dorsal vagal complex (DVC) significantly increased food intake measured 1.5 and 3 h after treatment. The response was obtained with a 10-pmol dose, establishing the DVC as a site of action with at least comparable sensitivity to that reported for the arcuate nucleus. Taken together, the results affirm a caudal brainstem site of action and recommend further investigation into multisite interactions underlying the modulation of ingestive behavior by ghrelin.

Footnotes

  • D.E.C. has received honoraria for speaking engagements from Abbot and Merck.

    • Accepted June 12, 2003.
    • Received February 18, 2003.
« Previous | Next Article »Table of Contents